Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-Site Randomized Trial of Inpatient Palliative Care for Patients With Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation

NCT03641378 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03641378
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03641378 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-Site Randomized Trial of Inpatient Palliative Care for Patients With Hematologic Malignancies Undergoing Hematopoietic Stem Cell Transplantation
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2018
Completion date
July 1, 2023
Enrollment
546 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

stem cell transplant